PAR 5.36% 29.5¢ paradigm biopharmaceuticals limited..

Ann: Paradigm AGM Presentation, page-64

  1. 1,559 Posts.
    lightbulb Created with Sketch. 619
    Yes I agree. It is great to be aligned with these world experts. Really looking forward to those publications and their endorsement of PPS by association. I recalled that in that talk last year she mentioned she is an author of a patent for using CRAC1 as an OA biomarker. Here it is...
    https://patents.google.com/patent/WO2016127035A1/
    Priority date is 2015 so its possible that things have progressed further in the last 7 years (the limited stuff we have published on COMP ADAMTS5 and CTXII is also pretty compelling). Either way its going to be interesting to see the results in more detail when published and how much interest it generates!



 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.